Skip to main content
Leisha Emens, MD, Oncology, Baltimore, MD

Leisha Ann Emens MD PhD


Professor of Medicine, University of Pittsburgh, UPMC Hillman Cancer Center; Co-Leader, Hillman Cancer Immunology and Immunotherapy Program; Director, Translational Immunotherapy for the Women's Cancer Research Center, Magee Women's Hospital

Join to View Full Profile
  • 600 N Wolfe StSuite 4628Baltimore, MD 21287

  • Phone+1 410-955-8964

  • Fax+1 412-623-1212

Dr. Emens is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1998 - 2002
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1995 - 1998
  • Baylor College of Medicine
    Baylor College of MedicineClass of 1995

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2024 - 2026
  • MD State Medical License
    MD State Medical License 1998 - 2026
  • PA State Medical License
    PA State Medical License 2018 - 2026
  • TX State Medical License
    TX State Medical License 1997 - 1999
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2012-2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
  • America's Top Doctors for Cancer Castle Connolly, 2011-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of Cancer Immunotherapy with Acute Macular Neuroretinopathy and Diffuse Retinal Venulitis  
    Sharon Solomon, Christopher H Lieu, Ashvini Reddy, Leisha A Emens, S Lindsey Davis, Lingmin He, JAMA

Lectures

  • Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer 
    International Society for Biological Therapy of Cancer (iSBTc)/ Society for Immunotherapy of Cancer, - 10/24/2012
  • Breast and Gynecologic Cancers. Integrating Immunotherapy Into Clinical Practice: Changes Over the Past Year (Part 1) 
    2018 ASCO Annual Meeting - Chicago, Illinois - 05/31/2018

Press Mentions

  • Ankyra Therapeutics Appoints Leisha a. Emens, M.D., Ph.D., as Senior Vice President, Translational Research
    Ankyra Therapeutics Appoints Leisha a. Emens, M.D., Ph.D., as Senior Vice President, Translational ResearchDecember 7th, 2022
  • Crisis in Oncology Research Demands Urgent Action, Stakeholders Say
    Crisis in Oncology Research Demands Urgent Action, Stakeholders SayNovember 4th, 2022
  • Society for Immunotherapy of Cancer Publishes Clinical Practice Guideline on Immunotherapy for the Treatment of Breast Cancer
    Society for Immunotherapy of Cancer Publishes Clinical Practice Guideline on Immunotherapy for the Treatment of Breast CancerAugust 18th, 2021
  • Join now to see all

Grant Support

  • Chemoimmunotherapy For Breast Cancer TreatmentNational Cancer Institute2003–2006

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: